Correlation between three dimensional multi-slice sonohysterography and hysteroscopy in the diagnosis and classification of submucous myomas

Negm, Sherif; Kamel, Rasha; Momtaz, M.; Magdi, Ahmed M.; Azab, Hamdy

doi:10.1016/j.mefs.2010.07.004

Cited by 5 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The myometrial free margin is a limiting factor for safe myoma resection during hysteroscopic myomectomy, but we can fix this problem by taking advantage of the contractile capacity of the myometrium with different pressure changes of the distension medium [24].…”

Section: Other Diagnostic Proceduresmentioning

confidence: 99%

Fibroids and Hysteroscopy: An Overview

Mazo¹

2021

Fibroids

View full text Add to dashboard Cite

Submucosal fibroids account for 10% of total fibroids. They significantly impact quality of life causing abnormal uterine bleeding (AUB), reduction in fertility rates/infertility, obstetrics complications and abdominal pain. They are a major public health concern because of economic cost their monitoring and treatment requires. Hysteroscopic myomectomy is the first line minimally invasive and conservative surgical treatment. Treating a fibroid correctly implies knowing its physiopathology: What is a submucosal fibroids and what is its origin, what is the Pseudocapsule?. Proper diagnosis and standardized classification such as the Wamsteker classification are required. What are the limits to perform a hysteroscopic myomectomy? What devices are currently used? What are the requirements for conducting myomectomy procedures in the outpatient setting?. Different forms of surgical approach. Complications and consequences of a myomectomy. What will we do in the future with the management of small submucosal fibroids in asymptomatic patients with future genetic desires and can we resect type 3 fibroids by hysteroscopy avoiding a higher risk surgery by abdominal route?

show abstract

Section: Other Diagnostic Proceduresmentioning

confidence: 99%

Fibroids and Hysteroscopy: An Overview

Mazo¹

2021

Fibroids

View full text Add to dashboard Cite

show abstract

“…The results of a survey for patients with submucous myoma of the uterus showed that the disease can have a greater impact on the fertility and menstrual status of patients, and cause infertility, hemorrhagic anemia and other symptoms ( 2 , 3 ). At present, the traditional treatment methods of myoma of the uterus include the myomaenucleation and hysterectomy, but the above methods have the disadvantages of large trauma, serious postoperative adverse reactions and longer postoperative recovery ( 4 ) so there have been some minimally-invasive clinical treatment means in previous years ( 5 – 7 ). As one of the important parts in ultrasound medicine, interventional ultrasound plays an important role in the clinical diagnosis and treatment of various diseases.…”

Section: Introductionmentioning

confidence: 99%

Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound

Liang

Xie

et al. 2018

Oncol Lett

View full text Add to dashboard Cite

The value of interventional ultrasound in the diagnosis and treatment of submucous myoma of the uterus was assessed to study the ultrasonographic features of modified sonohysterography for submucous polyp of uterus. A total of 25 patients diagnosed preliminarily as submucous myoma of the uterus via conventional ultrasound examination from June 2014 to December 2016 were enrolled in the study. The diagnosis was made via the comprehensive analysis of ultrasound-guided modified SHG, followed by ultrasound-guided needle biopsy and sclerotherapy of tumor. After modified SHG and ultrasound-guided needle biopsy, 96% (24/25) cases were confirmed pathologically as submucous myoma of the uterus. After treatment, the maximum diameter of myoma in patients with submucous myoma of uterus was significantly different, and the volume of myoma was significantly reduced. After treatment, the clinical symptoms of patients with submucous myoma of the uterus were obviously improved compared to before treatment (P<0.05). It was found in the follow-up after treatment that a small number of patients suffered from mild abdominal pain, increased secretion, slight vaginal bleeding, cold sweat, pale complexion, dizziness and other symptoms, which, however, disappeared after treatment for about 1 week. The score of 36 item Short-Form Health Survey Questionnaire of patients with submucous myoma of the uterus was significantly different before and after treatment (P<0.05). Interventional ultrasonography can effectively diagnose the submucous myoma of uterus. The treatment of submucous myoma of uterus with ultrasound-guided intratumor injection of lauromacrogol is characterized by simple operation, which can effectively reduce the tumor diameter and volume, improve the blood flow in patients, reduce the postoperative adverse reactions and alleviate the patient's pain, so it is a new type of minimally invasive treatment method of submucous myoma of the uterus, and it is worthy of clinical promotion and application.

show abstract

“…Hysteroscopic removal is the most effective treatment [ 9 , 10 ] and is the standard minimally invasive surgical procedure for treating submucous fibroids. Uterine bleeding and infertility are the most frequent indications for surgical excision of the tumor.…”

Section: Introductionmentioning

confidence: 99%

Office Hysteroscopic Laser Enucleation of Submucous Myomas without Mass Extraction: A Case Series Study

Haimovich

López-Yarto

Avila

et al. 2015

BioMed Research International

View full text Add to dashboard Cite

Background and Objectives. A new two-step hysteroscopic myomectomy carried out in the office setting and without anesthesia was feasible for the excision of submucous myomas. The objective of this study was to assess whether removal of submucous myomas from the uterine cavity after hysteroscopic laser enucleation is necessary. Methods. Between June 2009 and April 2013, all outpatients with symptomatic myomatosis (bleeding, pelvic pain, and infertility) assessed ultrasonographically were eligible to participate in a prospective study. All patients underwent office hysteroscopic enucleation of submucous myomas. Enucleated myomas were left in the uterine cavity. Neither anesthesia nor antibiotic prophylaxis was used. Results. Sixty-one women (mean age: 47.3 years) were included. Regardless of hysteroscopic localization and grading, all myomas were enucleated. The mean (standard deviation, SD) diameter of the myoma as measured by the ultrasound scan was 22.6 (8.5) mm. In 29 cases (47.5%), the diameter of the resected myoma was >20 mm and in 10 cases (16.4%) >30 mm. After a mean follow-up of 68.2 (16.5) days, none of the patients showed a residual myoma inside the uterine cavity. Conclusions. The present results indicate that leaving laser-enucleated submucous myoma in the uterine cavity is a feasible and safe therapeutic option.

show abstract

Correlation between three dimensional multi-slice sonohysterography and hysteroscopy in the diagnosis and classification of submucous myomas

Cited by 5 publications

References 20 publications

Fibroids and Hysteroscopy: An Overview

Fibroids and Hysteroscopy: An Overview

Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound

Office Hysteroscopic Laser Enucleation of Submucous Myomas without Mass Extraction: A Case Series Study

Contact Info

Product

Resources

About